Detalles de la búsqueda
1.
Pharmacokinetic study of capivasertib and the CYP3A4 substrate midazolam in patients with advanced solid tumors.
Cancer Chemother Pharmacol;
2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38643311
2.
Pharmacokinetics of the Akt Serine/Threonine Protein Kinase Inhibitor, Capivasertib, Administered to Healthy Volunteers in the Presence and Absence of the CYP3A4 Inhibitor Itraconazole.
Clin Pharmacol Drug Dev;
12(9): 856-862, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37449963
3.
The effect of food and acid-reducing agents on the pharmacokinetic profile of capivasertib: Results from a randomized, crossover study.
Br J Clin Pharmacol;
89(11): 3330-3339, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37328269
4.
Using qualitative interviews to identify patient-reported clinical trial endpoints and analyses that are the most meaningful to patients with advanced breast cancer.
PLoS One;
18(1): e0280259, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36649275
5.
A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia.
BMC Cancer;
22(1): 1192, 2022 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36402993
6.
Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12.
Protein Eng Des Sel;
23(8): 653-61, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20551083
7.
Isolation of a small-molecule inhibitor of the antiapoptotic protein Bcl-xL from a DNA-encoded chemical library.
ChemMedChem;
5(4): 584-90, 2010 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-20229565
8.
A general method for the selection of high-level scFv and IgG antibody expression by stably transfected mammalian cells.
Protein Eng Des Sel;
22(3): 169-74, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19022802
9.
Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy.
Clin Cancer Res;
14(20): 6515-24, 2008 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18927291
10.
A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo.
Int J Cancer;
122(11): 2405-13, 2008 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18271006
Resultados
1 -
10
de 10
1
Próxima >
>>